Australian regulators again warn users of Medtronic’s Paradigm insulin pumps of the danger of accidental insulin overdose. Australian healthcare regulators issued renewed warnings to patients using Medtronic’s (NYSE:MDT) Paradigm insulin pumps, cautioning that an accidental button-press may result in a potentially dangerous overdose. The Paradigm pumps, which deliver both continuous and bolus-based doses of insulin, can switch from a zero bolus setting to a maximum dose with a single click when in certain modes.
Help employers find you! Check out all the jobs and post your resume.
